LeMaitre Vascular Inc. (LMAT) Gains Momentum in Niche Vascular Device Market with Strong International Sales Growth

LeMaitre Vascular, Inc. (LMAT) specializes in vascular disease products, with flagship products including Artegraft biologic graft and Valvulotomes. The company has shown strong growth, particularly in international sales, with revenue projected to grow 13-15% in 2025. LMAT focuses on niche vascular device markets valued under $200 million, with a direct sales force and distributor network in over 90 countries. The accelerated adoption of biologic grafts like Artegraft underscores LMAT's momentum in advancing vascular surgery solutions.